bf/NASDAQ:PRQR_icon.png

COM:PROQR

ProQR Therapeutics

  • Stock

Last Close

3.61

22/11 21:00

Market Cap

139.64M

Beta: -

Volume Today

390.09K

Avg: -

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediate...Show More

peer of